Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 1.288\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a Cc1noc(NC(=O)c2ccc(Cl)c(Cl)c2)c1Cl
b COc1ccc(NC(=O)CSc2ccc(F)cc2)cc1S(=O)(=O)N1CCCCC1
c CCCn1c2ccc(F)cc2c2nnc(SCCN3CCOCC3)nc21
d O=C(CCS(=O)(=O)Cc1ccc(Cl)cc1)NCCCN1CCOCC1
Answer: c. CCCn1c2ccc(F)cc2c2nnc(SCCN3CCOCC3)nc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c2ccc(F)cc2c2nnc(SCCN3CCOCC3)nc21
CCCn1c2ccc(F)cc2c2nnc(SCCN3CCOCC3)nc21
4-[2-[(8-fluoro-5-propyl-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]ethyl]morpholine